{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:38:52Z","timestamp":1768009132911,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T00:00:00Z","timestamp":1241740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00223-009-9249-3","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T13:46:37Z","timestamp":1241703997000},"page":"75-83","source":"Crossref","is-referenced-by-count":19,"title":["Etiopathogenesis of Hepatic Osteodystrophy in Wistar Rats with Cholestatic Liver Disease"],"prefix":"10.1007","volume":"85","author":[{"given":"F. A.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inalda","family":"Facincani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanda","family":"Jorgetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandra N. Z.","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 B.","family":"Volpon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciene M.","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J. A.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,8]]},"reference":[{"key":"9249_CR1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2265.2007.02765.x","volume":"66","author":"AT Albuquerque Taveira de","year":"2007","unstructured":"de Albuquerque Taveira AT, Fernandes MI, Galv\u00e3o LC, Sawamura R, de Mello Vieira E, de Paula FJ (2007) Impairment of bone mass development in children with chronic cholestatic liver disease. Clin Endocrinol 66:518\u2013523","journal-title":"Clin Endocrinol"},{"key":"9249_CR2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","volume":"103","author":"SF Hodgson","year":"1985","unstructured":"Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855\u2013860","journal-title":"Ann Intern Med"},{"key":"9249_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/8756-3282(86)90015-3","volume":"7","author":"AJ Stellon","year":"1986","unstructured":"Stellon AJ, Webb A, Compston J, Williams R (1986) Lack of osteomalacia in chronic cholestatic liver disease. Bone 7:181\u2013185","journal-title":"Bone"},{"key":"9249_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","volume":"83","author":"HF Herlong","year":"1982","unstructured":"Herlong HF, Recker RR, Maddrey WC (1982) Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 83:103\u2013108","journal-title":"Gastroenterology"},{"key":"9249_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.1840210138","volume":"21","author":"H Rosen","year":"1995","unstructured":"Rosen H (1995) Primary biliary cirrhosis and bone disease. Hepatology 21:253\u2013255","journal-title":"Hepatology"},{"key":"9249_CR6","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3748\/wjg.v12.i28.4504","volume":"12","author":"SW Merwe van der","year":"2006","unstructured":"van der Merwe SW, Conradie MM, Bond R, Olivier BJ, Fritz E, Nieuwoudt M, Delport R, Slavik T, Engelbrecht G, Kahn D, Shephard EG, Kotze MJ, de Villiers NP, Hough S (2006) Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting. World J Gastroenterol 12:4504\u20134510","journal-title":"World J Gastroenterol"},{"key":"9249_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","volume":"38","author":"F Szalay","year":"2003","unstructured":"Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P (2003) High serum osteoprotegerin and low RANKL in primary biliary cirrosis. J Hepatol 38:395\u2013400","journal-title":"J Hepatol"},{"key":"9249_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.19.2.85","volume":"19","author":"RG Long","year":"1978","unstructured":"Long RG, Meinhard E, Skinner RK, Varghese Z, Wills MR, Sherlock S (1978) Clinical, biochemical and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease. Gut 19:85\u201390","journal-title":"Gut"},{"key":"9249_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(77)92167-5","volume":"1","author":"JE Compston","year":"1977","unstructured":"Compston JE, Thompson RP (1977) Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1:721\u2013724","journal-title":"Lancet"},{"key":"9249_CR10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0016-5085(80)90865-3","volume":"78","author":"JS Reed","year":"1980","unstructured":"Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL (1980) Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology 78:512\u2013517","journal-title":"Gastroenterology"},{"key":"9249_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0016-5085(89)90783-X","volume":"96","author":"TH Diamond","year":"1989","unstructured":"Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S (1989) Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213\u2013221","journal-title":"Gastroenterology"},{"key":"9249_CR12","first-page":"1356","volume":"85","author":"N Gua\u00f1abens","year":"1990","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Mari\u00f1oso L, Branc\u00f3s A, Piera C, Serrano S, Rivera F, Rod\u00e9s J (1990) Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 85:1356\u20131362","journal-title":"Am J Gastroenterol"},{"key":"9249_CR13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","volume":"46","author":"J Collier","year":"2007","unstructured":"Collier J (2007) Bone disorders in chronic liver disease. Hepatology 46:1271\u20131278","journal-title":"Hepatology"},{"key":"9249_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840040101","volume":"4","author":"JA Cuthbert","year":"1984","unstructured":"Cuthbert JA, Pak CYC, Zerwekh JE, Glass KD, Combes B (1984) Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4:1\u20138","journal-title":"Hepatology"},{"key":"9249_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02555237","volume":"41","author":"MS Shih","year":"1987","unstructured":"Shih MS, Anderson C (1987) Does \u201chepatic osteodystrophy\u201d differ from peri- and postmenopausal osteoporosis? A histomorphometric study. Calcif Tissue Int 41:187\u2013191","journal-title":"Calcif Tissue Int"},{"key":"9249_CR16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.0106-9543.2002.01566.x","volume":"22","author":"Z Ackerman","year":"2002","unstructured":"Ackerman Z, Weinerb M, Amir G, Pollak RD (2002) Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease. Liver 22:166\u2013172","journal-title":"Liver"},{"key":"9249_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2003.11.032","volume":"40","author":"M Weinreb","year":"2004","unstructured":"Weinreb M, Pollak RD, Ackerman Z (2004) Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis. J Hepatol 40:385\u2013390","journal-title":"J Hepatol"},{"key":"9249_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2008.03302.x","volume":"70","author":"FJ Paula de","year":"2009","unstructured":"de Paula FJ, G\u00f3is-J\u00fanior MB, Aguiar-Oliveira MH, Pereira Fde A, Oliveira CR, Pereira RM, Farias CT, Vicente TA, Salvatori R (2009) Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene. Clin Endocrinol 70:35\u201340","journal-title":"Clin Endocrinol"},{"key":"9249_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","volume":"110","author":"S Yakar","year":"2002","unstructured":"Yakar S, Rosen CJ, Beamer WG, Arkert-Bickenell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D (2002) Circulating levels of IGF-I directly regulate bone growth and density. J Clin Invest 110:771\u2013781","journal-title":"J Clin Invest"},{"key":"9249_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"9249_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2826.2006.01518.x","volume":"19","author":"MC Lebrethon","year":"2007","unstructured":"Lebrethon MC, Aganina A, Fournier M, G\u00e9rard A, Parent AS, Bourguignon JP (2007) Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty. J Neuroendocrinol 19:181\u2013188","journal-title":"J Neuroendocrinol"},{"key":"9249_CR22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ar.20650","volume":"291","author":"JA Horton","year":"2008","unstructured":"Horton JA, Bariteau JT, Loomis RM, Strauss JA, Damron TA (2008) Ontogeny of skeletal maturation in the juvenile rat. Anat Rec 291:283\u2013292","journal-title":"Anat Rec"},{"key":"9249_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.gastro.2007.10.025","volume":"134","author":"R Dresner-Pollak","year":"2008","unstructured":"Dresner-Pollak R, Gabet Y, Steimatzky A, Hamdani G, Bab I, Ackerman Z, Weinreb M (2008) Human parathyroid hormone 1\u201334 prevents bone loss in experimental biliary cirrhosis in rats. Gastroenterology 134:259\u2013267","journal-title":"Gastroenterology"},{"key":"9249_CR24","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"CH Janes","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AE, Riggs BL (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581\u20132586","journal-title":"J Clin Invest"},{"key":"9249_CR25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.52.4.580","volume":"52","author":"SW Merwe van der","year":"2003","unstructured":"van der Merwe SW, van den Bogaerde JB, Goosen C, Maree FF, Milner RJ, Schnitzler CM, Biscardi A, Mesquita JM, Engelbrecht G, Kahn D, Fevery J (2003) Hepatic osteodystrophy in rats results mainly from portasystemic shunting. Gut 52:580\u2013585","journal-title":"Gut"},{"key":"9249_CR26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2008.02.029","volume":"134","author":"MA Leonis","year":"2008","unstructured":"Leonis MA, Balisteri WF (2008) Evaluation and management of end-stage liver disease in children. Gastroenterology 134:1741\u20131751","journal-title":"Gastroenterology"},{"key":"9249_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0676.1996.tb00697.x","volume":"16","author":"Z Ackerman","year":"1996","unstructured":"Ackerman Z, Karmeli F, Amir G, Rachmilewitz D (1996) Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. Liver 16:12\u201318","journal-title":"Liver"},{"key":"9249_CR28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1440-1746.1996.tb01843.x","volume":"11","author":"A Nakano","year":"1996","unstructured":"Nakano A, Kanda T, Abe H (1996) Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J Gastroenterol Hepatol 11:1143\u20131154","journal-title":"J Gastroenterol Hepatol"},{"key":"9249_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0168-8278(98)80211-0","volume":"28","author":"A Cemborain","year":"1998","unstructured":"Cemborain A, Castilla-Cort\u00e1zar I, Garc\u00eda M, Quiroga J, Muguerza B, Picardi A, Santidri\u00e1n S, Prieto J (1998) Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol 28:122\u2013131","journal-title":"J Hepatol"},{"key":"9249_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03179904","volume":"56","author":"A Cemborain","year":"2000","unstructured":"Cemborain A, Castilla-Cort\u00e1zar I, Garc\u00eda M, Muguerza B, Delgado G, D\u00edaz-S\u00e1nchez M, Picardi A (2000) Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. J Physiol Biochem 56:91\u201399","journal-title":"J Physiol Biochem"},{"key":"9249_CR31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","volume":"36","author":"MM Guichelaar","year":"2002","unstructured":"Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE (2002) Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 36:895\u2013903","journal-title":"Hepatology"},{"key":"9249_CR32","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1164\/rccm.200206-578OC","volume":"166","author":"SL Elkin","year":"2002","unstructured":"Elkin SL, Vedi S, Bord S, Garrahan NJ, Hodson ME, Compston JE (2002) Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 166:1470\u20131474","journal-title":"Am J Respir Crit Care Med"},{"key":"9249_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF01623826","volume":"3","author":"PI Croucher","year":"1993","unstructured":"Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE (1993) Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int 3:236\u2013241","journal-title":"Osteoporos Int"},{"key":"9249_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1054\/ghir.2001.0236","volume":"11","author":"TL McCarthy","year":"2001","unstructured":"McCarthy TL, Centrella M (2001) Local IGF-I expression and bone formation. Growth Horm IGF Research 11:213\u2013219","journal-title":"Growth Horm IGF Research"},{"key":"9249_CR35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0168-8278(97)80161-4","volume":"27","author":"MC Blomsma","year":"1997","unstructured":"Blomsma MC, Knegt RJ, Dullaart RPFR, Jansen PL (1997) Insulin-like growth factor-I in liver cirrhosis. J Hepatol 27:1133\u20131138","journal-title":"J Hepatol"},{"key":"9249_CR36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10354-008-0594-z","volume":"158","author":"RW Gasser","year":"2008","unstructured":"Gasser RW (2008) Cholestasis and metabolic bone disease\u2014a clinical review. Wien Med Wochenschr 158:553\u2013557","journal-title":"Wien Med Wochenschr"},{"key":"9249_CR37","doi-asserted-by":"crossref","first-page":"B215","DOI":"10.1093\/geronj\/49.5.B215","volume":"49","author":"MR Benedict","year":"1994","unstructured":"Benedict MR, Lu MJ, Florini JR, Woo J, Richman RA (1994) The differential regulation of insulin-like growth factor (IGF) binding proteins by IGF-I during the life span of the rat. J Gerontol 49:B215\u2013B223","journal-title":"J Gerontol"},{"key":"9249_CR38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S8756-3282(97)00143-9","volume":"21","author":"CJ Rosen","year":"1997","unstructured":"Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ (1997) Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21:217\u2013223","journal-title":"Bone"},{"key":"9249_CR39","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","volume":"98","author":"N Guanabens","year":"2003","unstructured":"Guanabens N, Pares A, Ros I, Alvarez L, Pons F, Caballeria L, Monegal A, Martinez de Osaba MJ, Roca M, Peris P, Rodes J (2003) Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 98:2268\u20132274","journal-title":"Am J Gastroenterol"},{"key":"9249_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.gastro.2007.10.025","volume":"134","author":"R Dresner-Pollak","year":"2008","unstructured":"Dresner-Pollak R, Gabet Y, Steimatzky A, Hamdani G, Bab I, Ackerman Z, Weinreb M (2008) Human parathyroid hormone 1\u201334 prevents bone loss in experimental biliary cirrhosis in rats. Gastroenterology 134:259\u2013267","journal-title":"Gastroenterology"},{"key":"9249_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","volume":"25","author":"C Levy","year":"2005","unstructured":"Levy C, Harnois DM, Angulo P, Jorgensen R, Lindor KD (2005) Raloxifene improves bone mass in osteopenic woman with primary biliary cirrhosis: results of a pilot study. Liver Int 25:117\u2013121","journal-title":"Liver Int"},{"key":"9249_CR42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3748\/wjg.v9.i6.1287","volume":"9","author":"XZ Wang","year":"2003","unstructured":"Wang XZ, Chen ZX, Zhang LJ, Chen YX, Li D, Chen FL, Huang YH (2003) Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis. World J Gastroenterol 9:1287\u20131291","journal-title":"World J Gastroenterol"},{"key":"9249_CR43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1369\/jhc.6R7125.2006","volume":"55","author":"P Onori","year":"2007","unstructured":"Onori P, Alvaro D, Floreani A, Mancino MG, Franchitto A, Guido M, Carpino G, de Santis A, Angelico M, Attili AF, Gaudio E (2007) Activation of the IGF 1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. J Histochem Cytochem 55:327\u2013334","journal-title":"J Histochem Cytochem"},{"key":"9249_CR44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jhep.2005.04.011","volume":"43","author":"D Alvaro","year":"2005","unstructured":"Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B, Glaser SS, Francis H, Cantafora A, Blotta I, Attili AF, Gaudio E (2005) The intrahepatic biliary epithelium is a target of the growth hormone\/insulin-like growth factor 1 axis. J Hepatol 43:875\u2013883","journal-title":"J Hepatol"},{"key":"9249_CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005176-199608000-00007","volume":"23","author":"JC Bucuvalas","year":"1996","unstructured":"Bucuvalas JC, Horn JA, Slusher J, Alfaro MP, Chernausek SD (1996) Growth hormone insensitivity in children with biliary atresia. J Pediatr Gastroenterol Nutr 23:135\u2013140","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9249_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.1995.tb02031.x","volume":"43","author":"RC Cuneo","year":"1995","unstructured":"Cuneo RC, Hickman PE, Wallace JD, Teh BT, Ward G, Veldhuis JD, Waters MJ (1995) Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocrinol (Oxf) 43:265\u2013275","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9249_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/107999003321829944","volume":"23","author":"A Picardi","year":"2003","unstructured":"Picardi A, Gentilucci UV, Zardi EM, Caccavo D, Petitti T, Manfrini S, Pozzilli P, Afeltra A (2003) TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res 23:229\u2013235","journal-title":"J Interferon Cytokine Res"},{"key":"9249_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2008.02.013","volume":"49","author":"N Assy","year":"2008","unstructured":"Assy N, Pruzansky Y, Gaitini D, Orr ZS, Hochberg Z, Baruch Y (2008) Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction. J Hepatol 49:34\u201342","journal-title":"J Hepatol"},{"key":"9249_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.1840110121","volume":"11","author":"TC Chang","year":"1990","unstructured":"Chang TC, Lin JJ, Yu SC, Chang TJ (1990) Absence of growth hormone receptor in hepatocellular carcinoma and cirrhotic liver. Hepatology 11:123\u2013126","journal-title":"Hepatology"},{"key":"9249_CR50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0168-8278(02)00049-1","volume":"36","author":"AJ Donaghy","year":"2002","unstructured":"Donaghy AJ, Delhanty PJ, Ho KK, Williams R, Baxter RC (2002) Regulation of the growth hormone receptor\/binding protein, insulinlike growth factor ternary complex system in human cirrhosis. J Hepatol 36:751\u2013758","journal-title":"J Hepatol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9249-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-009-9249-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9249-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T05:45:06Z","timestamp":1710308706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-009-9249-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9249"],"URL":"https:\/\/doi.org\/10.1007\/s00223-009-9249-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,8]]}}}